Â¥
8.46
Nov 29
New Key Statistics Module, Z-Score and F-Score
SHSE:600267 Key Ratios
Market Cap ¥ M | 10,218.61 |
Enterprise Value ¥ M | 13,419.94 |
P/E(ttm) | -- |
PE Ratio without NRI | 30.99 |
Forward PE Ratio | 22.85 |
Price/Book | 1.24 |
Price/Sales | 1.07 |
Price/Free Cash Flow | 6.51 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 9,546.00 |
EPS (TTM) ¥ | -0.02 |
Beneish M-Score | -3.08 |
10-y EBITDA Growth Rate % | 3.10 |
5-y EBITDA Growth Rate % | -3.10 |
y-y EBITDA Growth Rate % | -86.60 |
EV-to-EBIT | 101.91 |
EV-to-EBITDA | 101.91 |
PEG | -- |
Shares Outstanding M | 1,207.87 |
Net Margin (%) | -0.21 |
Operating Margin % | 5.01 |
Pre-tax Margin (%) | -0.43 |
Quick Ratio | 0.65 |
Current Ratio | 0.93 |
ROA % (ttm) | -0.12 |
ROE % (ttm) | -0.25 |
ROIC % (ttm) | 3.58 |
Dividend Yield % | -- |
Altman Z-Score | 1.58 |
SHSE:600267 Number of Guru Trades
SHSE:600267 Volume of Guru Trades
Gurus Latest Trades with SHSE:600267
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600267 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Hisun Pharmaceutical Co Ltd Insider Transactions
No Available Data